IRVINE, Calif.--(BUSINESS WIRE)--MiCardia Corporation announced today the United States Patent Office has notified the Company that a new patent has been issued. This key patent, titled, “Adjustable Cardiovascular Implants and Methods for Reshaping Tissue,” along with the recently issued patent titled, “Shape Memory Devices and Methods for Reshaping Heart Anatomy,” surround the foundation of MiCardia’s Dynaplasty Technology.
